Chromatographic and spectroscopic properties of hemiacetals of aflatoxin and sterigmatocystin metabolites.
Improved fluorescence detection of aflatoxin B1 by chromatographic analysis is accomplished by conversion to the corresponding hemiacetal, aflatoxin B2a. Because the metabolites aflatoxin M1, aflatoxin P1, aflatoxin Q1, sterigmatocystin, and O-methylsterigmatocystin have the same molecular conversion site, we investigated the chromatographic and spectroscopic properties of hemiacetals of these compounds to assist in confirming aflatoxins and sterigmatocystins in human urine. Nuclear magnetic resonance and infrared absorbance were used to confirm the hemiacetal structure for aflatoxin B1 and sterigmatocystin. The ultraviolet absorbance, fluorescence, and chromatographic properties of the metabolites were investigated. Using these data, we optimized the detection and solvent conditions for high-performance liquid chromatography. We determined that, of the conditions studied, maximum sensitivity and resolution for the native aflatoxins were achieved with a mobile phase of methanol, tetrahydrofuran, and water, a C8 column in series with a C18 column, and fluorescence detection with 365 nm excitation and 430 nm emission wavelengths for aflatoxins B1 and M1 and with 500 nm emission wavelength for aflatoxins P1 and Q1. For the analysis of the hemiacetals, a mobile phase of methanol, acetonitrile, and water provided better chromatography and fluorescence detection. Sterigmatocystin and O-methylsterigmatocystin were readily converted to the hemiacetal forms, which, like the aflatoxins, were more polar and, therefore, earlier eluting by reversed-phase HPLC (methanol, acetonitrile, and water, 236 nm absorbance). These data are important to maximize the sensitivity and confidence for detecting the mycotoxin metabolites in biological specimens.
Orti
D L
DL
Division of Environmental Health Laboratory Sciences, Centers for Disease Control, Atlanta, GA 30333.
Grainger
J
J
Ashley
D L
DL
Hill
R H
RH
D000080:Acetals / Q000032:analysis*; D000348:Aflatoxins / Q000032:analysis* / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D006801:Humans; D009183:Mycotoxins / Q000378:metabolism / Q000652:urine; D013050:Spectrometry, Fluorescence / Q000379:methods; D013241:Sterigmatocystin / Q000032:analysis* / Q000378:metabolism; D014966:Xanthenes / Q000032:analysis*
D000080:Acetals; D000348:Aflatoxins; D009183:Mycotoxins; D014966:Xanthenes; D013241:Sterigmatocystin